NM_001127644.2:c.857-8C>T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate

The NM_001127644.2(GABRA1):​c.857-8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00013 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

GABRA1
NM_001127644.2 splice_region, intron

Scores

2
Splicing: ADA: 0.0003600
2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.150

Publications

0 publications found
Variant links:
Genes affected
GABRA1 (HGNC:4075): (gamma-aminobutyric acid type A receptor subunit alpha1) This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. Mutations in this gene cause juvenile myoclonic epilepsy and childhood absence epilepsy type 4. Multiple transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jul 2008]
GABRA1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 19
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • epilepsy, idiopathic generalized, susceptibility to, 13
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • Dravet syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • juvenile myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 5-161895658-C-T is Benign according to our data. Variant chr5-161895658-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 468881.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127644.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA1
NM_001127644.2
MANE Select
c.857-8C>T
splice_region intron
N/ANP_001121116.1
GABRA1
NM_000806.5
c.857-8C>T
splice_region intron
N/ANP_000797.2
GABRA1
NM_001127643.2
c.857-8C>T
splice_region intron
N/ANP_001121115.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA1
ENST00000393943.10
TSL:1 MANE Select
c.857-8C>T
splice_region intron
N/AENSP00000377517.4
GABRA1
ENST00000023897.10
TSL:1
c.857-8C>T
splice_region intron
N/AENSP00000023897.6
GABRA1
ENST00000428797.7
TSL:1
c.857-8C>T
splice_region intron
N/AENSP00000393097.2

Frequencies

GnomAD3 genomes
AF:
0.000141
AC:
21
AN:
148610
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000247
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000164
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000694
AC:
163
AN:
234864
AF XY:
0.000630
show subpopulations
Gnomad AFR exome
AF:
0.000983
Gnomad AMR exome
AF:
0.0000618
Gnomad ASJ exome
AF:
0.00115
Gnomad EAS exome
AF:
0.000117
Gnomad FIN exome
AF:
0.000940
Gnomad NFE exome
AF:
0.000940
Gnomad OTH exome
AF:
0.00175
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000131
AC:
189
AN:
1441862
Hom.:
0
Cov.:
35
AF XY:
0.000125
AC XY:
90
AN XY:
717316
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000799
AC:
26
AN:
32536
American (AMR)
AF:
0.000213
AC:
9
AN:
42348
Ashkenazi Jewish (ASJ)
AF:
0.000350
AC:
9
AN:
25734
East Asian (EAS)
AF:
0.0000508
AC:
2
AN:
39354
South Asian (SAS)
AF:
0.0000236
AC:
2
AN:
84856
European-Finnish (FIN)
AF:
0.000271
AC:
14
AN:
51584
Middle Eastern (MID)
AF:
0.000530
AC:
3
AN:
5664
European-Non Finnish (NFE)
AF:
0.0000982
AC:
108
AN:
1100196
Other (OTH)
AF:
0.000269
AC:
16
AN:
59590
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.259
Heterozygous variant carriers
0
21
42
64
85
106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000141
AC:
21
AN:
148610
Hom.:
0
Cov.:
31
AF XY:
0.000180
AC XY:
13
AN XY:
72322
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000247
AC:
1
AN:
40462
American (AMR)
AF:
0.00
AC:
0
AN:
15060
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3440
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5086
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4740
European-Finnish (FIN)
AF:
0.000944
AC:
9
AN:
9534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.000164
AC:
11
AN:
67024
Other (OTH)
AF:
0.00
AC:
0
AN:
2050
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.270
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0124
Hom.:
0

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Idiopathic generalized epilepsy;C1970160:Epilepsy, childhood absence 4;C4013473:Epilepsy, idiopathic generalized, susceptibility to, 13 Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
3.2
DANN
Benign
0.45
PhyloP100
-0.15

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00036
dbscSNV1_RF
Benign
0.022
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs752572964; hg19: chr5-161322664; COSMIC: COSV50109512; COSMIC: COSV50109512; API